Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field.

Humans Mycobacterium tuberculosis Tuberculosis Granuloma T-Lymphocytes Neoplasms / therapy Tumor Microenvironment
Mycobacterium tuberculosis T cell cancer granuloma immune checkpoint inhibitor (ICI) immunity macrophage tuberculosis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 01 10 2022
accepted: 30 11 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 4 1 2023
Statut: epublish

Résumé

Tuberculosis (TB) remains one of the deadliest infectious diseases in the world and every 20 seconds a person dies from TB. An important attribute of human TB is induction of a granulomatous inflammation that creates a dynamic range of local microenvironments in infected organs, where the immune responses may be considerably different compared to the systemic circulation. New and improved technologies for

Identifiants

DOI: 10.3389/fimmu.2022.1059725 PMID: 36591229 PMC: PMC9797505
pubmed: 36591229
doi: 10.3389/fimmu.2022.1059725
pmc: PMC9797505
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1059725

Informations de copyright

Copyright © 2022 Ashenafi and Brighenti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Gene Ther. 2021 Feb;28(1-2):5-17
pubmed: 32457487
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Crit Rev Microbiol. 2017 Mar;43(2):133-141
pubmed: 27800700
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
J Pathol. 2006 Jan;208(2):261-9
pubmed: 16362982
Semin Immunopathol. 2015 May;37(3):239-49
pubmed: 25917388
Cell Prolif. 2019 Jul;52(4):e12649
pubmed: 31199047
Am J Respir Crit Care Med. 2016 Aug 1;194(3):345-55
pubmed: 26882070
PLoS One. 2013;8(1):e55788
pubmed: 23383283
Lancet Oncol. 2020 Jan;21(1):e55-e65
pubmed: 31908308
Front Immunol. 2022 Apr 11;13:862084
pubmed: 35493449
J Biomed Sci. 2019 Oct 20;26(1):78
pubmed: 31629410
Commun Biol. 2022 May 19;5(1):480
pubmed: 35590096
Nature. 2015 Jan 29;517(7536):612-5
pubmed: 25470057
Pathog Dis. 2020 Feb 1;78(1):
pubmed: 32068828
Front Immunol. 2012 Mar 21;3:51
pubmed: 22566933
Infect Immun. 2001 Dec;69(12):7711-7
pubmed: 11705952
Immunol Cell Biol. 2006 Oct;84(5):467-74
pubmed: 16869940
Nat Rev Immunol. 2001 Oct;1(1):20-30
pubmed: 11905811
Front Immunol. 2021 Jan 20;11:613638
pubmed: 33552077
Cell Death Dis. 2015 Jun 18;6:e1792
pubmed: 26086965
Oncogene. 2022 May;41(20):2798-2810
pubmed: 35411033
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
J Exp Med. 2007 Sep 3;204(9):2159-69
pubmed: 17709423
Cells. 2020 May 13;9(5):
pubmed: 32413966
Matrix Biol Plus. 2022 Jan 28;13:100101
pubmed: 35198964
Cell Rep. 2021 Sep 14;36(11):109696
pubmed: 34525366
Immunity. 2007 Oct;27(4):635-46
pubmed: 17919943
Front Immunol. 2022 May 06;13:747799
pubmed: 35603185
Front Biosci. 2007 May 01;12:4298-314
pubmed: 17485376
Eur Respir J. 2022 Sep 15;60(3):
pubmed: 35169026
Clin Exp Immunol. 2017 Feb;187(2):269-283
pubmed: 27665733
Respir Res. 2018 Apr 18;19(1):66
pubmed: 29669565
Am J Respir Crit Care Med. 2018 Jul 1;198(1):104-116
pubmed: 29425052
Am J Respir Cell Mol Biol. 2003 Jul;29(1):28-38
pubmed: 12600829
Nat Med. 2020 May;26(5):693-698
pubmed: 32405063
Cell. 2009 Jan 9;136(1):37-49
pubmed: 19135887
J Immunol. 2007 Apr 1;178(7):4051-61
pubmed: 17371959
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1451-1453
pubmed: 30141960
Front Immunol. 2022 Jul 06;13:844142
pubmed: 35874717
JAMA Otolaryngol Head Neck Surg. 2020 Feb 1;146(2):128-135
pubmed: 31804658
Med (N Y). 2021 Mar 12;2(3):217-232
pubmed: 34693385
Immunity. 2014 Dec 18;41(6):960-72
pubmed: 25526309
J Exp Clin Cancer Res. 2021 Oct 16;40(1):326
pubmed: 34656158
Front Immunol. 2018 Jan 22;9:14
pubmed: 29403496
PLoS One. 2013 Apr 22;8(4):e61333
pubmed: 23613834
Front Immunol. 2021 Sep 24;12:753940
pubmed: 34630433
Cancers (Basel). 2020 Sep 28;12(10):
pubmed: 32998446
Sci Rep. 2016 Nov 15;6:37211
pubmed: 27845414
mBio. 2022 Nov 21;:e0302022
pubmed: 36409085
Immunol Cell Biol. 2019 Mar;97(3):246-257
pubmed: 30768869
PLoS One. 2017 Sep 7;12(9):e0180413
pubmed: 28880895
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Nat Immunol. 2020 Nov;21(11):1346-1358
pubmed: 32868929
Cell. 2014 Jun 5;157(6):1309-1323
pubmed: 24906149
Annu Rev Immunol. 2018 Apr 26;36:639-665
pubmed: 29400999
Nat Cell Biol. 2015 Feb;17(2):170-82
pubmed: 25580734
Mucosal Immunol. 2018 Mar;11(2):462-473
pubmed: 28745326
N Engl J Med. 1996 Dec 26;335(26):1941-9
pubmed: 8960473
Immunity. 2022 May 10;55(5):827-846.e10
pubmed: 35483355
Front Cell Infect Microbiol. 2018 Sep 18;8:327
pubmed: 30283745
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050
pubmed: 29632196
J Clin Invest. 2020 Jun 1;130(6):3158-3171
pubmed: 32163377
Infect Immun. 2007 Nov;75(11):5210-22
pubmed: 17664265
Oncoimmunology. 2012 Nov 1;1(8):1433-1434
pubmed: 23243619
J Med Primatol. 2012 Jun;41(3):191-201
pubmed: 22429048
Sci Immunol. 2018 Aug 31;3(26):
pubmed: 30171080
Nat Immunol. 2022 Feb;23(2):318-329
pubmed: 35058616
Infect Immun. 2001 Apr;69(4):2666-74
pubmed: 11254633
Pathog Dis. 2022 Apr 29;80(1):
pubmed: 35438161
J Theor Biol. 2017 Sep 21;429:1-17
pubmed: 28642013
J Immunol. 2007 Mar 1;178(5):2661-5
pubmed: 17312107
Front Immunol. 2020 Jan 22;10:3070
pubmed: 32038621
J Transl Med. 2020 Feb 18;18(1):92
pubmed: 32070368
Front Immunol. 2019 Apr 30;10:917
pubmed: 31114578
Arch Pharm Res. 2022 Jun;45(6):401-416
pubmed: 35759090
PLoS One. 2015 Jul 02;10(7):e0132249
pubmed: 26133981
Front Immunol. 2013 Jan 07;3:411
pubmed: 23308075
Front Pharmacol. 2015 Sep 02;6:184
pubmed: 26388774
Front Immunol. 2014 Oct 27;5:532
pubmed: 25386178
PLoS Comput Biol. 2020 Dec 28;16(12):e1008520
pubmed: 33370784
PLoS One. 2015 Jun 19;10(6):e0129744
pubmed: 26091535
ESMO Open. 2020 Aug;5(4):
pubmed: 32817069
Elife. 2020 Feb 24;9:
pubmed: 32091388
Vet Pathol. 2018 Jan;55(1):14-26
pubmed: 28749750
Br J Cancer. 2021 Jan;124(2):359-367
pubmed: 32929195
Int J Tuberc Lung Dis. 2004 Sep;8(9):1134-7
pubmed: 15455601
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013-7
pubmed: 1465432
Int J Oncol. 2017 Jul;51(1):104-114
pubmed: 28498427
Cell Rep. 2019 May 14;27(7):2119-2131.e6
pubmed: 31091450
mBio. 2020 Jul 7;11(4):
pubmed: 32636249
J Immunol. 2019 Jan 15;202(2):421-427
pubmed: 30559320
Indian J Med Res. 2018 May;147(5):456-463
pubmed: 30082569
Front Immunol. 2022 Feb 28;13:790113
pubmed: 35296094
Science. 1998 Oct 2;282(5386):121-5
pubmed: 9756476
J Immunol. 2016 Mar 15;196(6):2847-59
pubmed: 26873985
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651320
Cell Host Microbe. 2021 Feb 10;29(2):165-178.e8
pubmed: 33340449
Blood. 2006 Sep 1;108(5):1627-34
pubmed: 16709924
Nat Med. 2016 Feb;22(2):210-6
pubmed: 26752517
Front Immunol. 2021 Apr 26;12:594376
pubmed: 33981297
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3168-76
pubmed: 23093667
Clin Immunol. 2015 Feb;156(2):85-97
pubmed: 25510482
Immunotherapy. 2017 Jan;9(1):83-97
pubmed: 28000524
Eur Respir J. 2022 Nov 10;60(5):
pubmed: 35595321
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5
pubmed: 15070757
Cell. 2021 Apr 1;184(7):1757-1774.e14
pubmed: 33761328
Am J Pathol. 2022 Apr;192(4):653-670
pubmed: 35092727
Front Microbiol. 2017 Dec 05;8:2370
pubmed: 29259583
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
Sci Rep. 2019 Jan 17;9(1):187
pubmed: 30655556
Int Immunol. 2010 Mar;22(3):179-89
pubmed: 20139174
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12210-5
pubmed: 11035787
Trends Immunol. 2013 Jan;34(1):33-40
pubmed: 22999714
Theranostics. 2021 Mar 11;11(11):5365-5386
pubmed: 33859752
J Pathol. 2014 Nov;234(3):338-50
pubmed: 24979482
J Infect Dis. 2001 Oct 15;184(8):1082-5
pubmed: 11574927
Sci Rep. 2020 May 15;10(1):8056
pubmed: 32415175
Sci Immunol. 2021 Jan 15;6(55):
pubmed: 33452107
Cell Rep. 2022 May 31;39(9):110896
pubmed: 35649361
J Clin Invest. 2020 Jun 1;130(6):2789-2799
pubmed: 32420917
Mucosal Immunol. 2011 May;4(3):271-8
pubmed: 21430653
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Am J Respir Crit Care Med. 2012 May 1;185(9):989-97
pubmed: 22345579
PLoS Pathog. 2016 May 31;12(5):e1005667
pubmed: 27244558
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586
Semin Immunopathol. 2020 Jun;42(3):279-313
pubmed: 32519148
Nat Commun. 2019 Apr 23;10(1):1823
pubmed: 31015452
Eur J Immunol. 2017 May;47(5):765-779
pubmed: 28393361
J Immunol. 2013 Jul 15;191(2):773-84
pubmed: 23749634
Nat Med. 2007 Jul;13(7):843-50
pubmed: 17558415
Cancer Biol Ther. 2018 Aug 3;19(8):695-705
pubmed: 29621426
Front Immunol. 2018 Mar 23;9:585
pubmed: 29662491
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54
pubmed: 17671115
Cell Mol Life Sci. 2018 Feb;75(4):689-713
pubmed: 29032503
Front Immunol. 2022 Mar 28;13:837645
pubmed: 35418973
Clin Microbiol Rev. 2011 Apr;24(2):351-76
pubmed: 21482729
Immunol Rev. 2014 Nov;262(1):179-92
pubmed: 25319335
Cell Rep. 2022 May 17;39(7):110826
pubmed: 35584684
Ann Maxillofac Surg. 2011 Jul;1(2):150-4
pubmed: 23482819
Immunology. 2021 Feb;162(2):145-159
pubmed: 33020911
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Front Immunol. 2019 Sep 11;10:2139
pubmed: 31572365
J Immunol. 2005 Feb 15;174(4):2021-9
pubmed: 15699131
J Immunol. 2005 Dec 1;175(11):7474-83
pubmed: 16301655
Front Immunol. 2021 Aug 04;12:694680
pubmed: 34421903
Exp Suppl. 2022;113:107-140
pubmed: 35165862
J Thorac Dis. 2017 May;9(5):1353-1360
pubmed: 28616288
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1827-32
pubmed: 25624495
Scand J Immunol. 2015 Oct;82(4):370-9
pubmed: 26073153
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii54-8
pubmed: 12379623
J Infect Dis. 2010 Aug 15;202(4):533-41
pubmed: 20617900
J Exp Med. 2013 Jul 1;210(7):1389-402
pubmed: 23752227
Macrophage (Houst). 2015;2(1):e562
pubmed: 26029742
mBio. 2021 Dec 21;12(6):e0318921
pubmed: 34903057
Life Sci. 2020 May 15;249:117534
pubmed: 32156548
Am J Respir Crit Care Med. 2003 Dec 1;168(11):1346-52
pubmed: 12969871
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008
pubmed: 31028147
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51
pubmed: 18042719
J Immunol. 2011 Feb 1;186(3):1598-607
pubmed: 21172867
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):E62-E71
pubmed: 29255022
Curr Opin Pharmacol. 2017 Aug;35:12-19
pubmed: 28538141
Am J Respir Cell Mol Biol. 2001 Nov;25(5):606-12
pubmed: 11713103
PLoS Pathog. 2016 Mar 11;12(3):e1005490
pubmed: 26967901
Am J Pathol. 2009 Jun;174(6):2211-24
pubmed: 19435796
Cell Rep. 2020 Jan 14;30(2):335-350.e4
pubmed: 31940480
Mol Cancer. 2020 Aug 6;19(1):120
pubmed: 32762681
J Innate Immun. 2015;7(1):11-24
pubmed: 25196698
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
J Clin Invest. 2009 May;119(5):1167-77
pubmed: 19381021
J Intern Med. 2018 May 27;:
pubmed: 29804292
JAMA. 2001 Apr 4;285(13):1736-45
pubmed: 11277828
Int J Mol Sci. 2020 Aug 26;21(17):
pubmed: 32858811
Cell Rep. 2020 Jan 7;30(1):124-136.e4
pubmed: 31914380
Am J Respir Crit Care Med. 2013 Sep 15;188(6):724-32
pubmed: 23885784
Clin Exp Immunol. 2014 Oct;178(1):79-85
pubmed: 24894428
Tuberculosis (Edinb). 2009 May;89(3):195-8
pubmed: 19345146
Lancet Infect Dis. 2004 Dec;4(12):739-49
pubmed: 15567123
Front Immunol. 2018 Dec 19;9:2976
pubmed: 30619333
Immunology. 2008 Mar;123(3):326-38
pubmed: 17983439
Sci Transl Med. 2021 Jan 13;13(576):
pubmed: 33441427
JCI Insight. 2016 Sep 8;1(14):e86017
pubmed: 27699232
Cell Host Microbe. 2018 Sep 12;24(3):439-446.e4
pubmed: 30146391
J Infect Dis. 2012 May 15;205 Suppl 2:S316-24
pubmed: 22448014
Front Immunol. 2020 May 15;11:938
pubmed: 32499785
Front Immunol. 2020 May 15;11:940
pubmed: 32499786

Auteurs

Senait Ashenafi (S)

Department of Medicine Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, ANA Futura, Huddinge, Sweden.
Department of Pathology, School of Medicine, College of Health Sciences, Tikur Anbessa Specialized Hospital and Addis Ababa University, Addis Ababa, Ethiopia.

Susanna Brighenti (S)

Department of Medicine Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, ANA Futura, Huddinge, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Granulome › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › Tumeurs › Reinventing the human tuberculosis (TB)...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › Reinventing the human tuberculosis (TB)...